COMMUNIQUÉS West-GlobeNewswire

Meeting Growing National Demand, USAHS Expands MS-SLP Program to Florida and California Campuses

24/10/2024 - 16:05

The move reinforces USAHS's status as a provider of exceptional healthcare education. ST. AUGUSTINE, Fla., Oct. 24, 2024 (GLOBE NEWSWIRE) -- The University of St. Augustine for Health Sciences (USAHS) has made its [...]

Le KFSHRC réalise la première greffe de lobe gauche du foie robotisée au monde

24/10/2024 - 16:43

Cette nouvelle technique devrait permettre d’étendre la transplantation robotique à un plus grand nombre de patients RIYAD, Arabie saoudite, 24 oct. 2024 (GLOBE NEWSWIRE) -- Le King Faisal Specialist Hospital and [...]

Women’s Health Collective Canada accueille un nouveau membre, l’IWK Foundation, renforçant ainsi son alliance nationale en faveur de la recherche en santé des femmes

24/10/2024 - 16:45

TORONTO, 24 oct. 2024 (GLOBE NEWSWIRE) -- Women’s Health Collective Canada (association canadienne pour l’équité en santé des femmes) , alliance stratégique d’importantes fondations canadiennes du domaine de la santé [...]

Women’s Health Collective Canada Welcomes the IWK Foundation as Its Newest Member, Expanding National Alliance for the Advancement of Women’s Health Research

24/10/2024 - 16:45

TORONTO, Oct. 24, 2024 (GLOBE NEWSWIRE) -- Women’s Health Collective Canada (WHCC) , a strategic alliance of leading women’s health and hospital foundations from across Canada, is proud to announce the addition of the [...]

ONWARD® Medical Publishes Prospectus for Listing of New Shares

24/10/2024 - 17:45

THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE (7)(1) OF THE EUROPEAN MARKET ABUSE REGULATION (596/2014) EINDHOVEN, the Netherlands, Oct. 24, 2024 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. ( [...]

GUERBET : Revenue at September 30, 2024.

24/10/2024 - 17:45

Revenue at September 30, 2024 Continued growth momentum 9-month revenue: €620.5m, up 9.6% at CER 1 In the third quarter, momentum remained strong (+5.4% at CER), driven by the Americas (+13.1%) and Asia (+8.1%), while [...]

GUERBET : Chiffre d’affaires au 30 septembre 2024.

24/10/2024 - 17:45

Chiffre d’affaires au 30 septembre 2024 Maintien de la dynamique de croissance Chiffre d’affaires à 9 mois : 620,5 M€, en hausse de 9,6% à TCC 1 Au troisième trimestre, la dynamique est restée soutenue (+5,4% à TCC), [...]

Eurobio Scientific : ouverture de l’offre publique d’achat jusqu’au 27 novembre

24/10/2024 - 18:00

Eurobio Scientific : ouverture de l’offre publique d’achat jusqu’au 27 novembre Paris, le 24 octobre 2024 – 18h00 Eurobio Scientific (FR0013240934, ALERS, éligible PEA-PME), groupe français leader dans le diagnostic [...]

ORYZON Reports Financial Results and Corporate Update for Quarter Ended September 30, 2024

24/10/2024 - 18:08

Final data from PORTICO, global Phase IIb vafidemstat trial in BPD, presented at the 37th ECNP annual conference in September Company moving forward with PORTICO-2 Phase III trial preparations following positive [...]

Raw Garden Launches Live Resin Sauce Cartridges: Award-Winning Live Resin in a Convenient Ceramic Cartridge

24/10/2024 - 18:10

Experience the full spectrum effects and flavor of dabbable live resin in an easy-to-use, on-the-go cartridge SANTA BARBARA, Calif., Oct. 24, 2024 (GLOBE NEWSWIRE) -- Raw Garden, the #1 concentrates brand in California [...]

CBD Life Sciences Inc. (CBDL) Positioned for Significant Growth Amid Nationwide Marijuana Legalization Push

24/10/2024 - 18:42

With the potential for explosive profits in a $70 billion industry, CBDL's innovative product line and strategic market positioning stand ready to deliver unparalleled returns for shareholders, making this a true game [...]

Inside information: Orion terminates ODM-111 development program due to narrow therapeutic window of the molecule

24/10/2024 - 18:50

ORION CORPORATION STOCK EXCHANGE RELEASE – INSIDE INFORMATION 24 OCTOBER 2024 at 19.50 EEST Inside information: Orion terminates ODM-111 development program due to narrow therapeutic window of the molecule Orion [...]

Inozyme Pharma Announces Positive Interim Data from Phase 1 SEAPORT 1 Trial of INZ-701

24/10/2024 - 19:15

- INZ-701 was well-tolerated and significantly increased plasma pyrophosphate (PPi) levels in patients with end-stage kidney disease (ESKD) undergoing hemodialysis; low PPi levels are associated with calciphylaxis, a [...]

Un chirurgien saoudien récompensé pour avoir réalisé la première transplantation cardiaque robotisée au monde

24/10/2024 - 19:21

« Intervention chirurgicale cardiaque robotisée » au KFSHRC...Un parcours de réussite à la fois pionnier et en pleine accélération RIYAD, Arabie saoudite, 24 oct. 2024 (GLOBE NEWSWIRE) -- Le King Faisal Specialist [...]

Mustang Bio Announces Exercise of Warrants for $4 Million Gross Proceeds

24/10/2024 - 20:10

WORCESTER, Mass., Oct. 24, 2024 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang” or the “Company”) (Nasdaq: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell [...]

INmune Bio Inc. Announces Publication in Cell Reports Demonstrating XPro™ Promotes Remyelination

24/10/2024 - 21:03

Data from Animal Model Study Demonstrate XPro™ converts m icroglia from a demyelinating cell to a remyelinating cell Multi-year study published has implications for many CNS diseases including Alzheimer’s Boca Raton, [...]

Lyell Immunopharma to Acquire ImmPACT Bio and Prioritizes its Pipeline to Focus on Next-Generation CAR T-cell Therapies

24/10/2024 - 22:00

Strengthens Lyell’s clinical pipeline with the addition of IMPT-314, a dual-targeting CD19/CD20 CAR T-cell product candidate Data from ImmPACT’s multi-center Phase 1-2 clinical trial of IMPT-314 in patients with large B [...]

Teknova to Report Third Quarter 2024 Financial Results on November 7, 2024

24/10/2024 - 22:01

HOLLISTER, Calif., Oct. 24, 2024 (GLOBE NEWSWIRE) -- Alpha Teknova, Inc. (“Teknova”) (Nasdaq: TKNO), a leading producer of critical reagents for the discovery, development, and commercialization of novel therapies, [...]

Ardelyx Shares Additional Data Supporting First-In-Class XPHOZAH® (tenapanor) at the American Society of Nephrology’s Kidney Week

24/10/2024 - 22:05

WALTHAM, Mass., Oct. 24, 2024 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet [...]